DC
UTHR icon

Deere & Company’s United Therapeutics UTHR Stock Holding History

Deere & Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,983
Closed -$1.3M – 723
2016
Q3 		$1.3M Hold
10,983
– – 0.07% 320
2016
Q2 		$1.16M Sell
10,983
-2,056
-16% -$229K 0.06% 340
2016
Q1 		$1.45M Buy
13,039
+2,678
+26% +$339K 0.08% 295
2015
Q4 		$1.62M Sell
10,361
-135
-1% -$19.7K 0.09% 256
2015
Q3 		$1.38M Buy
+10,496
New +$1.68M 0.09% 279
2015
Q2 		– Sell
-11,898
Closed -$2.05M – 1110
2015
Q1 		$2.05M Buy
11,898
+5,913
+99% +$901K 0.11% 199
2014
Q4 		$775K Hold
5,985
– – 0.04% 468
2014
Q3 		$770K Sell
5,985
-4,390
-42% -$453K 0.04% 456
2014
Q2 		$918K Buy
10,375
+2,436
+31% +$234K 0.05% 404
2014
Q1 		$747K Buy
7,939
+2,836
+56% +$290K 0.04% 478
2013
Q4 		$577K Sell
5,103
-1,111
-18% -$100K 0.03% 640
2013
Q3 		$490K Hold
6,214
– – 0.03% 660
2013
Q2 		$409K Buy
+6,214
New +$400K 0.03% 684

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Deere & Company's UTHR Position: Q4 2016 in Review

Deere & Company sold out of United Therapeutics (UTHR) in Q4 2016, closing a stake of 10,983 shares — an estimated $1.3M sold.

Deere & Company first reported a position in UTHR in Q2 2013 and held it in 13 quarters. The position peaked at $2.05M in Q1 2015. 406 funds tracked by Wall St. Rank hold UTHR as of Q4 2016.

  • Deere & Company reported no remaining United Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 10,983 United Therapeutics shares in Q4 2016, an estimated $1.3M.
  • Deere & Company first reported a position in United Therapeutics in Q2 2013 and held it in 13 quarters.
  • Deere & Company's United Therapeutics position peaked at $2.05M in Q1 2015.
  • 406 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.